331 studies found for:    Open Studies | "Prednisone"
Show Display Options
Rank Status Study
1 Recruiting The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach
Conditions: Granulomatosis With Polyangiitis;   Wegener Granulomatosis;   Vasculitis
Interventions: Drug: 5 mg prednisone;   Drug: 0 mg prednisone
2 Recruiting The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach
Condition: Granulomatosis With Polyangiitis
Interventions: Drug: Prednisone 5 mg/day;   Drug: Prednisone 0 mg/day
3 Recruiting Use of a Single Dose of Oral Prednisone in the Treatment of Cellulitis
Condition: Cellulitis
Interventions: Drug: Prednisone;   Drug: Placebo
4 Recruiting Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy
Condition: IgA Nephropathy
Interventions: Drug: prednisone plus cyclophosphamide;   Drug: Prednisone alone
5 Recruiting Prednisone Versus Doxycycline in the Treatment of Graves' Orbitopathy
Condition: Thyroid Associated Opthalmopathies
Interventions: Drug: Prednisone+placebo of Doxycycline;   Drug: Doxycycline+placebo of Prednisone
6 Recruiting Efficacy of Prednisone in Patients With Severe Systemic Atheroembolism (Cholesterol Cristal Embolism)
Condition: Cholesterol Embolism Systemic
Interventions: Drug: prednisone;   Other: placebo
7 Unknown  The Use of Oral Steroids in the Treatment of Cellulitis
Conditions: Cellulitis;   Erysipelas
Intervention: Drug: Prednisone
8 Unknown  Therapeutic Effect of Low-dose Prednisone Combined With MMF and FK506 in Focal Segmental Glomerulosclerosis
Condition: Focal Segmental Glomerulosclerosis
Interventions: Drug: prednisone, FK506, MMF;   Drug: prednisone
9 Recruiting Short-term Prednisone to Treat STA Study(SPTSS)
Condition: Subacute Thyroiditis
Interventions: Drug: Prednisone 1 week;   Drug: Prednisone 6 weeks
10 Recruiting Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: Alisertib;   Drug: Abiraterone acetate;   Drug: Prednisone
11 Recruiting Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1;   Untreated Adult Acute Lymphoblastic Leukemia
Interventions: Biological: Blinatumomab;   Drug: Dasatinib;   Other: Laboratory Biomarker Analysis;   Drug: Mercaptopurine;   Drug: Methotrexate;   Drug: Prednisone;   Drug: Vincristine Sulfate
12 Recruiting Feasibility of a Chemotherapy With Docetaxel-Prednisone for Castration-resistant Metastatic Prostate Cancer Elderly Patients
Condition: Prostate Cancer
Interventions: Drug: Docetaxel every 3 weeks + Prednisone;   Drug: Docetaxel weekly+ Prednisone
13 Not yet recruiting Prednisone Plus Chloroquine for the Treatment of Hyper-reactive Malarial Splenomegaly
Conditions: Hyper-reactive Malarial Splenomegaly;   Malaria;   Anaemia
Interventions: Drug: prednisone induction - chloroquine;   Drug: Chloroquine
14 Recruiting Theophylline and Steroids in Chronic Obstructive Pulmonary Disease (COPD) Study
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Theophylline;   Drug: Prednisone;   Drug: Placebo (for prednisone);   Drug: Placebo (for Theophylline)
15 Not yet recruiting Prednisone in Chronic Rhinosinusitis Without Nasal Polyps
Conditions: Sinusitis;   Chronic Rhinosinusitis
Interventions: Drug: Prednisone;   Drug: Placebo
16 Recruiting Finite Androgen Ablation vs. Finite Androgen Ablation in Combination With Abiraterone Acetate and Prednisone
Condition: Prostate Cancer
Interventions: Drug: Lupron;   Drug: Zoladex;   Drug: Degarelix;   Drug: Abiraterone Acetate;   Drug: Prednisone
17 Recruiting Preventing TB-IRIS in High-risk Patients: a Randomized Placebo-controlled Trial of Prednisone
Conditions: Immune Reconstitution Inflammatory Syndrome;   HIV;   Tuberculosis
Interventions: Drug: Prednisone;   Drug: Placebo
18 Recruiting Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Conditions: Hormone-Resistant Prostate Cancer;   Recurrent Prostate Carcinoma;   Stage IV Prostate Cancer
Interventions: Drug: Abiraterone Acetate;   Other: Laboratory Biomarker Analysis;   Drug: Prednisone;   Drug: Veliparib
19 Unknown  Effect of Steroids on Thrombosis (Blood Clot Formation) and Inflammation in Patients Undergoing Hip Surgery
Condition: Total Hip Replacement
Interventions: Drug: Prednisone;   Drug: Hydrocortisone;   Drug: Placebo (for Prednisone)
20 Recruiting Revlimid, Endoxan, Prednison Evaluation After Prior Revlimid Treatment (REPEAT)
Condition: Multiple Myeloma
Interventions: Drug: Lenalidomide, endoxan, prednisone;   Drug: lenalidomide, endoxan, prednisone

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years